🖼

Fig. 4 — Transfer of mitochondria from astrocytes to neurons after stroke.

active
paper figure Created: 2026-04-21T18:29:40 By: paper_figures_tool Quality: 50% 🔗 External ID: paper-fig-d651da98-16e1-4493-81d8-3ed9f9
Fig. 4 — Transfer of mitochondria from astrocytes to neurons after stroke.
Fig. 4Figure 4
Effects of CD38 siRNA in focal cerebral ischemia a, Male C57Bl6 mice were subjected to transient 60 min focal ischemia and control siRNA or CD38 siRNA was injected into lateral ventricles at 5 days post-stroke. Immunostaining showed that CD38 siRNA decreased HMGB1 astrocytes in peri-infarct cortex. b, Nissl staining showed no difference in infarct size (n=8 or 10). c, Immunostaining demonstrated that astrocytic CD38 was diminished by CD38 siRNA. d, Astrocytic CD38 suppression with siRNA reduced GFAP-positive mitochondria in CSF at 7 days (n=6). e, Neuronal mitochondria were decreased by CD38 siRNA (n= 8 or 5). f, CD38 siRNA attenuated peri-infarct GAP43 immunostaining. g, Western blot confirmed a reduction of peri-infarct GAP43 protein within CD38 siRNA-treated brains (n=5). h, i, Suppression of CD38 signaling worsened neurological outcomes in neuroscore ( h ) and grid walking test ( i ) (n=7 or 9).* P <0.05 vs day 3 control siRNA, # P <0.05 vs day 7 CD38 siRNA. j, CD
PubMed: d651da98-16e1-4493-81d8-3ed9f9d6010e
Metadata
pmidd651da98-16e1-4493-81d8-3ed9f9d6010e
captionEffects of CD38 siRNA in focal cerebral ischemia a, Male C57Bl6 mice were subjected to transient 60 min focal ischemia and control siRNA or CD38 siRNA was injected into lateral ventricles at 5 days p
image_urlhttps://www.ebi.ac.uk/europepmc/articles/PMC4968589/bin/nihms795847f4.jpg
paper_titleTransfer of mitochondria from astrocytes to neurons after stroke.
figure_labelFig. 4
figure_number4
_schema_version1
source_strategypmc_api
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.